# General Drug Use-results Survey on PROPESS Vaginal Inserts in Treatment for Initiation of Cervical Ripening in Patients at Term (From 37 Completed Weeks of Gestation)

> **NCT04773314** · — · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 409 (actual)

## Conditions studied

- Cervical Ripening
- Pregnancy

## Interventions

- **OTHER:** PROPESS Cohort

## Key facts

- **NCT ID:** NCT04773314
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-28
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 409 (ACTUAL)
- **Last updated:** 2023-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04773314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04773314, "General Drug Use-results Survey on PROPESS Vaginal Inserts in Treatment for Initiation of Cervical Ripening in Patients at Term (From 37 Completed Weeks of Gestation)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04773314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*